The Failed Fundraise: What the Numbers Were Saying

The Situation

B2B SaaS startup, $3M ARR, raising a Series B ($10M target). Strong product, great team, impressive customer logos.

The pitch deck looked amazing: 150% YoY growth, 95% gross margin, $2M ARR from the top 10 customers.

Result: 12 VC pitches, 0 term sheets. Every VC said the same vague thing: "Love the product, but we'll pass for now."

What Most Would Do

Fix the pitch deck. Add more slides. Make it prettier. Pitch more VCs.

The Unfolding Values Analysis

VCs don't pass on "great numbers." They pass when the numbers don't make sense.

What the pitch deck DIDN'T show:

• Cohort analysis: The first 100 customers had -30% net retention
• Customer acquisition: The last 6 months of growth came from 3 large customers (9+ month sales cycles)
• Unit economics: CAC $45K, LTV $60K (a 1.3x ratio, barely viable)
• Revenue concentration: Top 3 customers = 40% of ARR

The "150% growth" was real. But it was coming from a handful of large deals, not a repeatable sales motion. The early customers were churning. The unit economics were broken.

VCs saw this in due diligence and passed.

The Decision Tree

Option A: Keep fundraising. Find a less sophisticated VC. Might close, but wrong partner, and the problem still exists.

Option B: Fix the business first. Addresses the root cause but takes 12-18 months, might run out of cash.

Option C: Fix then bridge (Recommended). Months 1-3: Fix retention. Months 4-6: Rebuild the narrative. Month 7: Raise a bridge. Months 12-18: Raise a proper Series B.

The Outcome

• Bridge round: Closed in 45 days ($2M at a $20M valuation)
• Retention fix: Net retention improved from -30% to +15% over 9 months
• Series B: Raised $8M at a $35M valuation (12 months after the bridge)

Key Principles

1. VCs pattern-match to failure modes. High growth + bad retention = they've seen this movie before.
2. The pitch deck is marketing. The financial model is truth.
3. Better to delay a fundraise and fix the business than raise on broken fundamentals.